Emergent BioSolutions reacts to BARDA’s Request for Proposal cancellation
Dec.16, 2009 in
Biopharmaceutical, Chief executive officer, Emergent BioSolutions, U.S. Food and Drug Administration, fuad el-hibri
Leave a Comment
by Nick Rees on December 8, 2009
Fuad El-Hibri
The Office of the Biomedical Advanced Research and Development Authority has advised Emergent BioSolutions that while BARDA’s Request for Proposal has been canceled, Emergent is encouraged to submit a proposal for the office’s Broad Agency Announcement.
BARDA canceled the RFP for the procurement for rPA vaccines after [...]